Lipid Hydroperoxide (LPO) Assay Kit
Be the first to review this product! Submit a review
|
(18 Publications)
- FuncS
Supplier Data
Functional Studies - Lipid Hydroperoxide (LPO) Assay Kit (AB133085)
Functional Studies - Lipid Hydroperoxide (LPO) Assay Kit. Typical standard curve obtained using lipid hydroperoxide standard provided in the kit.
Product details
Abcam's Lipid Hydroperoxide (LPO) Assay Kit (ab133085) measures the hydroperoxides directly utilizing the redox reactions with ferrous ions. Hydroperoxides are highly unstable and react readily with ferrous ions to produce ferric ions. The resulting ferric ions are detected using thiocyanate ion as the chromogen. Since this method relies on the measurement of ferric ions generated during the reaction, ferric ions present in the sample are a potential source of error. Also, many biological samples contain hydrogen peroxide which readily reacts with ferrous ions to give an over-estimation of lipid hydroperoxides. These problems are easily circumvented by performing the assay in chloroform.
An easy to use, quantitative extraction method was developed to extract lipid hydroperoxides into chloroform and the extract is directly used in the assay. This procedure eliminates any interference caused by hydrogen peroxide or endogenous ferric ions in the sample and provides a sensitive and reliable assay for lipid peroxidation.
Quantification of lipid peroxidation is essential to assess the role of oxidative injury in pathophysiological disorders. Lipid peroxidation results in the formation of highly reactive and unstable hydroperoxides of both saturated and unsaturated lipids. Traditionally, lipid peroxidation is quantified by measuring malondialdehyde (MDA) and 4-hydroxy nonenal (4-HNE), the degradation products of polyunsaturated fatty acids (PUFAs) hydroperoxides.
Sensitive colorimetric assays have been developed to measure these aldehydes. However, these assays are non-specific and often lead to an over-estimation of lipid peroxidation. There are important additional problems in using these by-products as indicators of lipid peroxidation. The by-product formation is highly inefficient and varies according to the transition metal ion content of the sample. Only hydroperoxides derived from PUFAs give rise to these by-products. For example, 4-HNE is formed only from omega-6 PUFA hydroperoxides and is catalyzed by transition metal ions like ferrous.
Decomposition of hydroperoxides derived from abundant cellular lipids such as cholesterol and oleic acid does not produce MDA or 4-HNE. These factors can lead to an under-estimation of lipid peroxidation. MDA is also produced in ng/ml concentrations by the platelet enzyme thromboxane synthase during whole blood clotting and platelet activation. This leads to gross over-estimation of lipid peroxidation. Estimation of lipid hydroperoxide levels range from 0.3-30 µM depending on the method used. However, direct methods of estimation suggest that the concentration in normal human plasma is approximately 0.5 µM. Given the limitations of the indirect methods, direct measurement of hydroperoxides is the obvious choice.
Related products
Review the oxidative stress marker and assay guide, or the full metabolism assay guide to learn about more assays for metabolites, metabolic enzymes, mitochondrial function, and oxidative stress, and also how to assay metabolic function in live cells using your plate reader.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Journal of microbiology and biotechnology 35:e2410040 PubMed39947675
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 22:283-297 PubMed39781518
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cardiovascular disorders 24:531 PubMed39354361
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 181:4245-4261 PubMed38978400
2024
Applications
Unspecified application
Species
Unspecified reactive species
Tropical biomedicine 40:453-461 PubMed38308833
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 27:3189-3201 PubMed37731202
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of environmental research and public health 19: PubMed36554566
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of reproductive biomedicine 20:413-422 PubMed35911861
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:9947191 PubMed35075382
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed33379332
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com